Corrigendum to “Structural elucidation and evaluation of multidrug-resistance modulatory capability of Amarissinins A-C, diterpenes derived from Salvia amarissima” [Fitoterapia 114 (2016) 1–6](S0367326X16301861)(10.1016/j.fitote.2016.08.007);Structural elucidation and evaluation of multidrug-resistance modulatory capability of amarissinins A–C, diterpenes derived from Salvia amarissima

Fitoterapia

Volumn 114, Issue , 2016, Pages 1-6

  Bautista, Elihú ^a,b   Fragoso Serrano, Mabel ^b   Ortiz Pastrana, Naytzé ^b   Toscano, Rubén A ^b   Ortega, Alfredo ^b  

^a INSTITUTO POTOSINO DE INVESTIGACIÓN CIENTÍFICA Y TECNOLÓGICA   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Clerodane diterpenes; Cytotoxic; Lamiaceae; MDR modulation; Salvia amarissima

Indexed keywords

AMARISSININ A; AMARISSININ B; AMARISSININ C; CYTOTOXIC AGENT; DITERPENE; PLANT EXTRACT; RESERPINE; UNCLASSIFIED DRUG; VINBLASTINE; ANTINEOPLASTIC AGENT; CLERODANE DERIVATIVE;

ARTICLE; CANCER CELL LINE; CARBON NUCLEAR MAGNETIC RESONANCE; CONTROLLED STUDY; CYTOTOXICITY; DRUG ISOLATION; DRUG STRUCTURE; EPIMER; FEMALE; FLOWER; HCT116 CELL LINE; HETERONUCLEAR MULTIPLE BOND CORRELATION; HUMAN; HUMAN CELL; IC50; MASS SPECTROMETRY; MCF 7 CELL LINE; MULTIDRUG RESISTANCE; PLANT LEAF; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SALVIA; SALVIA AMARISSIMA; X RAY DIFFRACTION; CHEMICAL STRUCTURE; CHEMISTRY; DRUG SCREENING; ISOLATION AND PURIFICATION; MCF-7 CELL LINE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; X RAY CRYSTALLOGRAPHY;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CRYSTALLOGRAPHY, X-RAY; DITERPENES, CLERODANE; DRUG RESISTANCE, MULTIPLE; DRUG SCREENING ASSAYS, ANTITUMOR; FLOWERS; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MCF-7 CELLS; MOLECULAR STRUCTURE; PLANT LEAVES; SALVIA;

EID: 84982296150     PISSN: 0367326X     EISSN: 18736971     Source Type: Journal    
DOI: 10.1016/j.fitote.2016.11.001     Document Type: Erratum

References (22)

1. [1] Kang, J., Li, L., Wang, D., Wang, H., Liu, C., Li, B., Yan, Y., Fang, L., Du, G., Chen, R., Isolation and bioactivity of diterpenoids from roots of Salvia grandifolia. Phytochemistry 116 (2015), 337–348.
2. [2] Martínez-Gordillo, M., Fragoso-Martínez, I., García-Peña, M.R., Montiel, O., Genera of Lamiaceae from Mexico, diversity and endemism. Rev. Mex. Biodivers. 84 (2013), 30–86.
3. [3] Jenks, A.A., Kim, S.C., Medicinal plant complexes of Salvia subgenus Calosphace: an ethnobotanical study of new world sages. J. Ethnopharmacol. 146 (2013), 214–224.
4. [4] Calzada, F., Bautista, E., Yépez-Mulia, L., García-Hernández, N., Ortega, A., Antiamoebic and antigiardial activity of clerodane diterpenes from Mexican Salvia species used to treatment of diarrhea. Phytother. Res. 29 (2015), 1600–1604.
5. [5] Bautista, E., Toscano, R.A., Ortega, A., 5,10-seco-neoclerodanes from Salvia microphylla. J. Nat. Prod. 77 (2014), 1088–1092.
6. [6] Yi-Bing, W., Zhi-Yu, N., Qing-Wen, S., Mei, D., Hiromasa, K., Yu-Cheng, G., Bin, C., Constituents from Salvia species and their biological activities. Chem. Rev. 112 (2012), 5967–6026.
7. [7] Bautista, E., Toscano, R.A., Ortega, A., Microphyllandiolide, a new diterpene with an unprecedented skeleton from Salvia microphylla. Org. Lett. 15 (2013), 3210–3213.
8. [8] Jaime-Vasconcelos, M.A., Frontana-Uribe, B.A., Morales-Serna, J.A., Salmón, M., Cárdenas, J., Structure of salvioccidentalin, a diterpenoid with a rearranged neoclerodane skeleton from Salvia occidentalis. Molecules 16 (2011), 9109–9115.
9. [9] Bautista, E., Maldonado, E., Ortega, A., Neo-clerodane diterpenes from Salvia herbacea. J. Nat. Prod. 75 (2012), 951–958.
10. [10] Kadioglu, O., Efferth, T., Pharmacogenomic characterization of cytotoxic compounds from Salvia officinalis in cancer cells. J. Nat. Prod. 78 (2015), 762–775.
11. [11] Ming, Q., Su, C., Zheng, C., Jia, M., Zhang, Q., Zhang, H., Rahman, K., Han, T., Qin, L., Elicitors from the endophytic fungus Trichoderma atroviride promote Salvia miltiorrhiza hairy root growth and tanshinone biosynthesis. J. Exp. Bot. 64 (2013), 5687–5694.
12. [12] Esquivel, B., Cárdenas, J., Rodríguez-Hahn, L., The diterpenoid constituents of Salvia fulgens and Salvia microphylla. J. Nat. Prod. 50 (1987), 738–740.
13. [13] Esquivel, B., Martínez, N.S., Cárdenas, J., Ramamoorthy, T.P., The pimarane-type diterpenoids of Salvia microphylla var. neurepia. Planta Med. 55 (1989), 62–63.
14. [14] Aydogmus, Z., Yesilyurt, V., Topcu, G., Constituents of Salvia microphylla. Nat. Prod. Res. 8 (2006), 775–781.
15. [15] Maldonado, E., Cárdenas, J., Bojórquez, H., Escamilla, E.M., Ortega., A., Amarisolide, a neo-clerodane diterpene glycoside from Salvia amarissima. Phytochemistry 42 (1996), 1105–1108.
16. [16] Bautista, E., Fragoso-Serrano, M., Toscano, R.A., García-Peña, M.R., Ortega, A., Teotihuacanin, a diterpene with an unnusual spiro-10/6 system from Salvia amarissima with potent modulatory activity of multidrug resistance in cancer cells. Org. Lett. 17 (2015), 3280–3282.
17. [17] Skehan, P., Storeng, R., Scudiero, D., Monks, A., McMahon, J., Vistica, D., Warren, J.T., Bokesch, H., Kenney, S., Boyd, M.R., New colorimetric cytotoxicity assay for anticancer drug screening. J. Natl. Cancer Inst. 82 (1990), 1107–1112.
18. [18] Figueroa-González, G., Jacobo-Herrera, N., Zentella-Dehesa, A., Pereda-Miranda, R., Reversal of multidrug resistance by morning glory resin glycosides in human breast cancer cells. J. Nat. Prod. 75 (2012), 93–97.
19. [19] Bautista, E., Toscano, R.A., Calzada, F., Díaz, E., Yépez-Mulia, L., Ortega, A., Hydroxyclerodanes from Salvia shannoni. J. Nat. Prod. 76 (2013), 1970–1975.
20. [20] Ortega, A., Cárdenas, J., Toscano, R.A., Maldonado, E., Aumelas, A., Van Calsteren, M.R., Jankowski, C., Salviandulines A and B. Two secoclerodane diterpenoids from Salvia lavanduloides. Phytochemistry 30 (1991), 3357–3360.
21. [21] Parsons, S., Flack, H., Precise absolute-structure determination in light-atom crystals. Acta Crystallogr., A60, 2004, s61.
22. [22] Xu, G., Zhao, F., Yang, W.X., Zhou, J., Yang, L.X., Shen, X.L., Hu, Y.J., Zhao, Q.S., Neo-Clerodane diterpenoids from Salvia dugesii and their bioactive studies. Nat. Prod. Bioprospect. 1 (2011), 81–86.